Bionow Precision Medicine Conference

Bionow Precision Medicine Conference

Citylabs, Manchester
Wednesday 18th September


The Business of Precision Medicine - Visioning the Future

Precision Medicine is putting the patient at the centre of healthcare and the Bionow Precision Medicine Conference will focus on the impact which this emerging field is having on patients and given the strengths in the North, how are we developing this approach in an efficient and sustainable way. 

Precision Medicine is the next generation of healthcare research that has the potential to provide significant benefits to patients, and affect strategic shifts in the way healthcare is delivered. It uses an individual's genetic profile to guide decisions about the prevention, diagnosis, and treatment of disease. Developing new diagnostic tests and expanding the use of biomarkers enables the identification of the molecular cause of disease, and ultimately supports the development of novel, more precisely targeted treatments. 

We are delighted to have Professor Sir Munir Pirmohamed, Head of Department of Molecular and Clinical Pharmacology at the University of Liverpool and NHS Chair of Pharmacogenetics and Peter Simpson Chief Scientific Officer at the Medicine Discovery Catapult giving the Keynote Addresses at the conference.

Conference Sponsors

Conference Agenda

  • Arrival & Registration

  • Welcome

    Dr Geoff Davison
    CEO, Bionow

  • Keynote Address

    Professor Sir Munir Pirmohamed
    Head of Department of Molecular and Clinical Pharmacology, University of Liverpool and NHS Chair of Pharmacogenetics 

  • Genomic Medicine

    Ariana Tucci, Clinical Fellow in Rare Diseases, Genomics England
    Tracy Briggs, Clinical Senior Lecturer, The Manchester Centre for Genomic Medicine
    Eamonn Sheridan, Professor of Clinical Genetics, University of Leeds

  • Coffee, Networking & Exhibition

  • Enabling Global Companion Diagnostic Testing, Development and Commercialisation

    QIAGEN Manchester
    Huw Ricketts, Director - Business Development, Partnering for Precision Diagnostics
    Jonathan Perkins, Associate Director Personalised Healthcare
    Ben Chaffey, Global Product Manager - Oncology & Precision Diagnostics

  • Driving Growth with Innovate UK

    Michael Kipping
    Innovation Lead, Innovate UK

  • Lunch, Networking & Exhibition

  • Keynote Address

    Dr Peter Simpson
    Chief Scientific Officer, Medicines Discovery Catapult

  • Precision Medicine in Oncology

    Chair: Jane Theaker, CEO, Kinomica
    Matthew Krebs, Clinical Senior Lecturer in Experimental Cancer Medicine and Honorary Consultant in Medical Oncology, The Christie
    Himanshu Kataria, CEO, Clyz Labs
    Steve Little, Vice Chairman, Yourgene Health

  • Coffee, Networking & Exhibition

  • Advanced Therapies in Precision Medicine

    Neil Watson, Director of Pharmacy, Newcastle Hospital Trust
    Gray Kueberuwa, Research Director - Molecular Immunology, Immetacyte
    Brian Biggar, Professor of Cell and Gene Therapy, University of Manchester

  • Shaping the Future of Precision Medicine

    Chair: James Fry, Partner, Mills & Reeve
    Lotte Steuten, Head of Consulting and Vice President, Office of Health Economics
    John Ainsworth, Director, Centre for Health Informatics
    Niels Peek, Professor of Health Informatics, Health eResearch Centre for North England

  • Close


Registration will open shortly. For any further queries please contact

Exhibitor Packages


Gold Exhibitor Package Silver Exhibitor Package
• 3m x 2m exhibition space with table and two chairs • 3m x 2m exhibition space with table and two chairs
• Two delegate passes     • One delegate pass  
• Company logo on delegate list   • Company logo on delegate list  
• Recognition as a gold exhibitor via twitter / linked-in   
• Company promotional/marketing literature in delegate bag  

To discuss any of the exhibitor packages please contact Helen Williams on 07714 168020 or at

Citylabs, Manchester


Citylabs 1.0 is a biomedical centre of excellence and has proved hugely successful in creating stronger links between the NHS, academia and industry and assisting businesses located there in substantial growth. Citylabs 1.0 is 100,000 sq ft of Grade A state of the art laboratory and office facilities in a beautiful Grade II listed building and new purpose-built facility for life science companies, joined by a stunning glass atrium.


Nelson Street
M13 9NQ

Tel: 0161 279 6969